phase 1 clinical - Robuta Search

https://news.cuanschutz.edu/news-stories/from-lab-to-clinic-cu-anschutz-launches-phase-1-clinical-trial-of-promising-combination-therapy-for-resistant-ovarian-cancer From Lab to Clinic: CU Anschutz Launches Phase 1 Clinical Trial of Promising Combination Therapy... Jan 29, 2026 - From lab to clinic: CU Anschutz launches phase 1 clinical trial of promising combination therapy for resistant ovarian cancer. phase 1 clinical cu anschutz combination therapy lab launches https://neurosciencenews.com/cortice-bioscience-tpi-287-7871/ Cortice Biosciences Announces Presentation of Results from Placebo-Controlled Phase 1 Clinical... Nov 4, 2017 - Cortice Biosciences announced today results from placebo-controlled, double-blinded Phase 1 studies evaluating TPI 287, a brain penetrable microtubule... phase 1 clinical biosciences announces placebo controlled presentation results https://www.globenewswire.com/news-release/2024/08/07/2926298/0/en/Angiex-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-AGX101-a-novel-TM4SF1-Directed-Antibody-Drug-Conjugate-for-the-Treatment-of-Solid-Tumors.html Angiex Announces First Patient Dosed in Phase 1 Clinical Aug 7, 2024 - CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- August 7, 2024: Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies... phase 1 clinical announces first patient dosed https://www.biospace.com/press-releases/tenvie-therapeutics-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-tnv262-a-fully-cns-penetrant-nlrp3-inhibitor Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV262, a Fully... phase 1 clinical therapeutics announces first subject dosing trial